Potassium Chloride

Product NDC: 66689-048
Requested package NDC: 66689-048-99
11-digit product format: 666890048
Labeler code: 66689
Product ID: 66689-048_2d1d7b4e-5ac0-46a0-ba85-0470b0935693
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Potassium Chloride
Dosage form: SOLUTION
Route: ORAL
Labeler: VistaPharm, Inc.
Application: NDA206814
Marketing category: NDA
Marketing start: 2015-02-15
Marketing end: 0000-00-00
Substance: POTASSIUM CHLORIDE
Active strength: 40 meq/30mL
Pharmacologic classes: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	66689-048	66689-048-99	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N206814-001	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22
N206814-002	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22
N206814-003	POKONZA	POTASSIUM CHLORIDE	10MEQ/15ML	SOLUTION / ORAL		RLD	2025-11-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N206814-001	AA
N206814-002	AA

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N206814-001	12539314	2039-03-07		Drug product	2026-02-04
N206814-002	12539314	2039-03-07		Drug product	2026-02-04

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206814-003	POKONZA	10MEQ/15ML	SOLUTION / ORAL		RLD	2025-11-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206814-003	POKONZA	10MEQ/15ML	SOLUTION / ORAL		RLD	2025-11-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206814-003	POKONZA	10MEQ/15ML	SOLUTION / ORAL		RLD	2025-11-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N206814-002	POTASSIUM CHLORIDE	40MEQ/15ML	SOLUTION / ORAL	AA	RLD, RS	2014-12-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206814-001	POTASSIUM CHLORIDE	20MEQ/15ML	SOLUTION / ORAL	AA	RLD	2014-12-22	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N206814-001	AA	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206814-002	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206814-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206814-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206814-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206814-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206814-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206814-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206814-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206814-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206814-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206814-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206814-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206814-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206814-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206814-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206814-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206814-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206814-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206814-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206814-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N206814-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206814-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206814-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206814-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206814-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206814-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206814-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206814-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N206814-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206814-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206814-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206814-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N206814-002	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206814-001	AA	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N206814-002	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206814-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N206814-002	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N206814-001	AA	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N206814-002	AA	1	`bb7c543d1eb4…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N206814-001	12539314	2039-03-07	Drug product	2026-02-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206814-002	12539314	2039-03-07	Drug product	2026-02-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206814-001	12539314	2039-03-07	Drug product	2026-02-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206814-002	12539314	2039-03-07	Drug product	2026-02-04	`011fe1cb6892…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N206814-001	12539314	2039-03-07	Drug product	2026-02-04	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N206814-002	12539314	2039-03-07	Drug product	2026-02-04	`a50c72e98297…`

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
66689-048-30	These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948
66689-048-50	These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948
66689-048-80	These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948
66689-048-99	These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66689-048-01	ML - Milliliter	66689-048	04048e35-54ff-49f7-a269-a76a390a11d9	1	2016-01-13
66689-048-30	ML - Milliliter	66689-048	bf6d3390-6215-4f17-a64c-b1d095d5acf9	1	2017-07-07
66689-048-50	ML - Milliliter	66689-048	601a4244-7b9f-44d2-b84d-dd5cf4948c80	1	2016-01-13
66689-048-80	ML - Milliliter	66689-048	170da888-dd49-4bf4-b773-89dd87c17eb6	1	2017-07-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Potassium Chloride	ACTIVE INGREDIENT	660YQ98I10	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Chloride Ion	ACTIVE MOIETY	Q32ZN48698	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Anhydrous Citric Acid	INACTIVE INGREDIENT	XF417D3PSL	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
FD&C Yellow NO. 6	INACTIVE INGREDIENT	H77VEI93A8	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Propylene Glycol	INACTIVE INGREDIENT	6DC9Q167V3	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Sucralose	INACTIVE INGREDIENT	96K6UQ3ZD4	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Trisodium Citrate Dihydrate	INACTIVE INGREDIENT	B22547B95K	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66689-048	POTASSIUM CHLORIDE SOLUTION [VISTAPHARM, LLC]	15	Legacy NDC	20240511_142c30ff-a839-4616-8167-ad4b07d8456f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
POKONZA potassium chloride	POTASSIUM CHLORIDE	Carwin Pharmaceutical Associates, LLC	2d938cbf-27aa-4f9c-a582-5564d3b72465	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (NDA): 206814 application number: NDA206814
Potassium Chloride	POTASSIUM CHLORIDE	Genus Lifesciences	14cd12ee-a4a3-465a-9550-58c9ef0e4f21	2025-07-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 206814 application number: NDA206814
Potassium Chloride	POTASSIUM CHLORIDE	Endo USA, Inc.	e5214432-3517-4a90-9412-036752bd1139	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (NDA): 206814 application number: NDA206814

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
660YQ98I10	POTASSIUM CHLORIDE	7447-40-7	POTASSIUM CHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
66689-048-99	66689004899	10 TRAY in 1 CASE (66689-048-99) > 10 CUP in 1 TRAY > 30 mL in 1 CUP (66689-048-01)	10 tray	2020-06-25	0000-00-00	No	No	Current